Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy
Yusuke Inoue, Naoki Inui, Masato Karayama, Kazuhiro Asada, Masato Fujii, Shun Matsuura, Tomohiro Uto, Dai Hashimoto, Takashi Matsui, Masaki Ikeda, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Takafumi Suda
Topics & Concepts
AtezolizumabMedicineOncologyNivolumabInternal medicineCohortCytokineLung cancerLog-rank testImmunotherapySurvival analysisCancerImmune Cell Function and InteractionCancer Immunotherapy and BiomarkersLymphoma Diagnosis and Treatment